The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
301
Sort by:
Philippines Orphan Drugs Market Size, Share, Trends and Forecast by Drug Type, Disease Type, Phase, Top Selling Drugs, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Philippines orphan drugs market size reached USD 1.2 Billion in 2025. Looking forward, the market is expected to reach USD 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 8.17% during 2026...
July 2026
122 pages
Europe GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 3,840.00
Europe GLP-1 / Weight Loss Drugs Market was valued at USD $1.57 billion in 2026 and is projected to reach USD $16.65 billion by 2035, registering a CAGR of 30.0% across the forecast period. The Europe...
July 2026
379 pages
United States GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 4,760.00
United States GLP-1 / Weight Loss Drugs Market was valued at USD $350 million in 2026 and is projected to reach USD $4.26 billion by 2035, registering a CAGR of 32.0% across the forecast period. The U...
July 2026
427 pages
GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America) and Regional Forecast 2026–2035
US$ 4,740.00
GLP-1 / Weight Loss Drugs Market was valued at USD $4.00 billion in 2026 and is projected to reach USD $48.67 billion by 2035, registering a CAGR of 32.0% across the forecast period. The GLP-1 / Weigh...
June 2026
430 pages
Orphan Drugs / Rare Disease Therapeutics Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America) and Regional Forecast 2026–2035
US$ 3,650.00
Orphan Drugs / Rare Disease Therapeutics Market was valued at USD $180 million in 2026 and is projected to reach USD $540 million by 2035, registering a CAGR of 13.0% across the forecast period. The O...
March 2026
371 pages
